December 31, 2020 Corporate and regulatory developments over the Christmas period Myovant and Pfizer showed that deal-making was not taking a Christmas break, but for Celgene CVR holders the dream is almost over. And vaccine approvals gained pace.
November 27, 2020 Go or no go? The year ends with Covid-19 vaccine approvals in sight December promises big US decisions for Novartis, Astrazeneca and Fibrogen, as well as the FDA's first Covid-19 vaccine reviews.
July 01, 2020 Go or no go? Pandemic looms over FDA timelines Approval decisions are due for Jazz, Gilead and Galapagos in July, while Glaxo is preparing for a panel.